Arturo Chiti researcher
Chiti, Arturo.
Chiti, Arturo 1962-
VIAF ID: 2382145857115322921596 (Personal)
Permalink: http://viaf.org/viaf/2382145857115322921596
Preferred Forms
- 100 0 _ ‡a Arturo Chiti ‡c researcher
-
- 100 1 _ ‡a Chiti, Arturo
-
- 100 1 _ ‡a Chiti, Arturo ‡d 1962-
- 100 1 _ ‡a Chiti, Arturo ‡d 1962-
-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
[(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors | |
Clinical applications of nuclear medicine targeted therapy / editors Emilio Bombardieri [et al.]. - Cham, © 2018. | |
Clinical nuclear medicine in pediatrics, 2016: | |
FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables | |
Feasibility of carbidopa premedication in pediatric patients: a pilot study | |
[Final scintigraphic diagnosis with [99mTc] HIDA in a case of focal nodular hyperplasia with essential thrombocythemia and portal thrombosis] | |
Fourier amplitude image circumferential profile analysis in the evaluation of the dipyridamole test | |
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study | |
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant | |
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper | |
Imaging acute spinal myelitis with 18F-FDG PET/CT. | |
Imaging biomarkers in oncology: we can get more from what we see. | |
Imaging biomarkers in primary brain tumours | |
Imaging of therapy response in oncology | |
Imaging struma ovarii by means of 124I-Na PET/CT. | |
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study. | |
Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) | |
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma. | |
Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer | |
Isotopic biomarker discovery and application in translational medicine. | |
Lung uptake of 201Tl in myocardial stress imaging: correlation with echocardiographic and scintigraphic variables of myocardial ischaemia | |
Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies | |
Metastatic gastric cancer presenting with shoulder-hand syndrome: a case report | |
Molecular imaging in radiotherapy planning for head and neck tumors | |
Myeloid neoplasms after chemotherapy and PRRT: myth and reality | |
Myocardial involvement in systemic sclerosis. | |
Nuclear medicine approaches for detection of axillary lymph node metastases | |
Nuclear medicine procedures in lung cancer. | |
Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm | |
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion | |
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data | |
PET in radiotherapy planning: particularly exquisite test or pending and experimental tool? | |
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology | |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning. | |
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy. | |
Predictive value of thyroglobulin changes for the efficacy of thyroid remnant ablation | |
Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancer | |
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. | |
Prone scintimammography in patients with non-palpable breast lesions | |
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma. | |
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail | |
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer | |
Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium | |
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies | |
Radionuclide assessment of left ventricular function in patients with myocardial infarction and diabetes mellitus. | |
Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results. | |
Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals. | |
Radiopharmaceuticals for breast cancer imaging | |
Re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literatur | |
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572–83 | |
Reply to comment on Pepe et al.: Somatostatin receptor SPECT. | |
Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging. | |
Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Experience of the National Cancer Institute of Milan. | |
The role of bone SPET study in diagnosis of single vertebral metastases | |
Salvage therapy of small volume prostate cancer nodal failures: a review of the literature. | |
[The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors] | |
Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1] | |
Shaping our future. | |
Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors | |
SNMMI/EANM guideline for guideline development 6.0. | |
Somatostatin receptor imaging of small cell lung cancer | |
Somatostatin receptor scintigraphy for bronchial carcinoid follow-up | |
Somatostatin receptor scintigraphy in a patient with an epigastric mass and multiple liver metastases | |
Standardization and quantification in PET/CT imaging: tracers beyond FDG. | |
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global Standardization. | |
Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). | |
Surgical procedures in the DANTE trial, a randomized study of lung cancer early detection with spiral computed tomography: comparative analysis in the screening and control arm. | |
Surgical sentinel lymph node biopsy in early breast cancer. Could it be avoided by performing a preoperative staging procedure? A pilot study. | |
Thallium-201 lung uptake: comparison of an automatic and a manual method of ROI drawing | |
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics | |
Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan. | |
[Utility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma] | |
Utility fo gallium-67 in determining the radicality of lymph node dissections of the neck for metastatic lymph nodes with extranodal spread in patients affected by carcinoma of the head and neck | |
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study | |
What impact can fluorine-18 fluorodeoxyglucose PET/computed tomography have on HIV/AIDS and tuberculosis pandemic? | |
What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients? | |
Why New Journals? The Growth of the EJNMMI Family | |
Writing PET into existence. |